David Shen
Vorstandsvorsitzender bei Proteologix US, Inc.
Profil
David Wenyan Shen is currently the Chairman & Chief Executive Officer at Proteologix US, Inc. He previously held positions as the Executive Director-Biologics Research at GlycoFi, Inc., Merck, Inc., and NGM Biopharmaceuticals, Inc. He also served as the Vice President-Biologics at Teva Pharmaceuticals USA, Inc. Dr. Shen holds a doctorate degree from the University of Toronto and an undergraduate degree from East China University of Science & Technology.
Aktive Positionen von David Shen
| Unternehmen | Position | Beginn |
|---|---|---|
Proteologix US, Inc.
 Proteologix US, Inc. BiotechnologyHealth Technology Proteologix US, Inc. is based in Redwood City, CA. Part of Johnson & Johnson, Proteologix US, Inc. is a biopharmaceutical company. The CEO of the company is David Wenyan Shen. Proteologix US was acquired by Johnson & Johnson on June 21, 2024 for $850 million. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von David Shen
| Unternehmen | Position | Ende |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.07.2021 |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Corporate Officer/Principal | - |
| Merck, Inc. | Corporate Officer/Principal | - |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
Ausbildung von David Shen
| University of Toronto | Doctorate Degree |
| East China University of Science & Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
GlycoFi, Inc.
GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
| Merck, Inc. | |
Proteologix US, Inc.
Proteologix US, Inc. BiotechnologyHealth Technology Proteologix US, Inc. is based in Redwood City, CA. Part of Johnson & Johnson, Proteologix US, Inc. is a biopharmaceutical company. The CEO of the company is David Wenyan Shen. Proteologix US was acquired by Johnson & Johnson on June 21, 2024 for $850 million. | Health Technology |
